These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8083563)

  • 21. In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.
    Valluri S; Fleming TP; Laycock KA; Tarle IS; Goldberg MA; Garcia-Ferrer FJ; Essary LR; Pepose JS
    Cornea; 1997 Sep; 16(5):556-9. PubMed ID: 9294689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis - a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.
    Lin T; Gong L; Sun XH; Zhao NQ; Chen W; Yuan HP; Shao Y; Gao MH; Tang H
    Drug Des Devel Ther; 2013; 7():361-8. PubMed ID: 23761964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. The Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 1996 Sep; 114(9):1065-72. PubMed ID: 8790090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of BW759 (9-[[2-hydroxy-1(hydroxymethyl)ethoxy]methyl]guanine) against herpes simplex virus type 1 keratitis in rabbits.
    Trousdale MD; Nesburn AB; Willey DE; Taaid H
    Curr Eye Res; 1984 Aug; 3(8):1007-15. PubMed ID: 6333319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis.
    Dhaliwal DK; Romanowski EG; Yates KA; Hu D; Mah FS; Fish DN; Gordon YJ
    J Cataract Refract Surg; 2001 Aug; 27(8):1288-93. PubMed ID: 11524202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor 2, heparin and suramin reduce epithelial ulcer development in experimental HSV-1 keratitis.
    Rieck P; Denis J; Peters D; Hartmann C; Pouliquen Y; Courtois Y
    Graefes Arch Clin Exp Ophthalmol; 1997 Nov; 235(11):733-40. PubMed ID: 9407232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of herpetic keratitis with acyclovir: benefits and problems.
    Ohashi Y
    Ophthalmologica; 1997; 211 Suppl 1():29-32. PubMed ID: 9065935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Battle with herpes for 37 years].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical treatment with nerve growth factor in an animal model of herpetic keratitis.
    Lambiase A; Coassin M; Costa N; Lauretti P; Micera A; Ghinelli E; Aloe L; Rama P; Bonini S
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):121-7. PubMed ID: 17479276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
    Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
    Itahashi M; Higaki S; Shimomura Y
    Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpetic stromal disease: response to acyclovir/steroid therapy.
    O'Brien WJ; Segundo AP; Guy J; Dorn EM; Taylor JL
    Acta Ophthalmol Scand; 1996 Jun; 74(3):265-70. PubMed ID: 8828724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
    Asbell PA; Epstein SP; Wallace JA; Epstein D; Stewart CC; Burger RM
    Cornea; 1998 Sep; 17(5):550-7. PubMed ID: 9756451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current management of herpetic eye disease.
    Collum LM; Power WJ; Collum A
    Doc Ophthalmol; 1992; 80(2):201-5. PubMed ID: 1425135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of honey to acyclovir in the rabbit eye transport kinetics].
    He Q; Wang S; Zhang X; Zhang J; Jiang Y; Xu J
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2723-6. PubMed ID: 22242438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilateral Herpetic Keratitis After Bilateral Intravitreal Bevacizumab for Exudative Macular Degeneration.
    Derham AM; Chen E; Bunya VY; OʼMalley RE
    Cornea; 2017 Jul; 36(7):878-879. PubMed ID: 28489722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
    Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
    J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiating effect of ribavirin on the anti-herpes activity of acyclovir.
    Pancheva SN
    Antiviral Res; 1991 Sep; 16(2):151-61. PubMed ID: 1665959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil in a rabbit model of herpetic keratitis.
    Trousdale MD; Law JL; Yarber FA; Watanabe KA; Fox JJ
    Antiviral Res; 1992 Feb; 17(2):157-67. PubMed ID: 1313221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.